Fraser HM
No ORCID on file
· 11 papers in corpus
· active 1982-2009
Study types
- review 5
- article 4
Condition tags
- endometriosis 8
- dysmenorrhea 1
- infertility 1
- dyspareunia 1
Top journals
Frequent coauthors
- Hamish M. Fraser 9
- Jürgen Sandow 4
- Sandow J 4
- S. K. Smith 2
- Cowen GM 2
- G M Cowen 2
- R. E. B. Haining 2
- Haining R 2
- Smith SK 2
- F Geisthövel 1
review
2009
The marked cyclical physiological angiogenesis in the developing follicle, corpus luteum and endometrium implies a critical role in health and disease. Our approach to understanding its regulation has been to localise and quantify the tempo…
review
2000
The rapid, controlled and cyclical nature of angiogenesis in the female reproductive tract suggests that interference with this process should provide a novel approach to manipulation of reproductive function. Many factors involved in the r…
article
1992
OBJECTIVE: The duration of action of a gonadotrophin releasing hormone (GnRH) agonist implant designed to be effective for 3 months was investigated in women by monitoring drug release and ovarian hormone secretion. Serum inhibin secretion …
article
1990
Ten endometriosis patients received luteinizing hormone releasing hormone (LH-RH) agonist (buserelin) implant injections (6.6 mg subcutaneously) at days 0, 42, 84 and 126. Serum LH and follicle-stimulating hormone (FSH) were lowered by day …
review
1989
review
1987
What is the current state of clinical application of inhibition of gonadal activity with LHRH agonists or antagonists? It seems unlikely in the short term that antagonists will be widely applied due to the short-acting nature of the present…
review
1986
article
1985
The effect of continuous administration of an LHRH agonist for 14 days on follicular estradiol secretion was studied in adult female stumptailed macaque monkeys. The infusion was started either during the early follicular phase or during th…
1984
article
1983
Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis.
An agonist analogue of luteinising hormone releasing hormone (buserelin) was successfully used to treat women with endometriosis. A dose of 200 micrograms administered intranasally thrice daily was found to be effective in five patients, in…
1982